Xin Lü

3.4k total citations
126 papers, 1.7k citations indexed

About

Xin Lü is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xin Lü has authored 126 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 35 papers in Oncology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xin Lü's work include Cholangiocarcinoma and Gallbladder Cancer Studies (31 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Xin Lü is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (31 papers), Inflammatory Biomarkers in Disease Prognosis (13 papers) and Pancreatic and Hepatic Oncology Research (11 papers). Xin Lü collaborates with scholars based in China, United States and United Kingdom. Xin Lü's co-authors include Xinting Sang, Haitao Zhao, Yiyao Xu, Kazuchika Yamauchi, Shiro Saka, Yilei Mao, Huayu Yang, Shouxian Zhong, Hanchun Huang and Xiaonan Fu and has published in prestigious journals such as The Lancet, Nature Communications and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Xin Lü

119 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Lü China 24 473 409 375 343 245 126 1.7k
Qing Sun China 26 698 1.5× 302 0.7× 413 1.1× 345 1.0× 291 1.2× 109 2.1k
Lei Geng China 22 571 1.2× 383 0.9× 340 0.9× 315 0.9× 288 1.2× 80 1.7k
Mitsuyoshi Takiguchi Japan 25 354 0.7× 171 0.4× 328 0.9× 115 0.3× 384 1.6× 178 2.1k
Hongyuan Zhou China 21 512 1.1× 436 1.1× 178 0.5× 184 0.5× 193 0.8× 56 1.3k
Shayan Mostafaei Iran 23 277 0.6× 226 0.6× 162 0.4× 184 0.5× 360 1.5× 82 1.4k
Zhenhua Luo China 23 429 0.9× 150 0.4× 306 0.8× 151 0.4× 134 0.5× 76 1.5k
Hongyan Diao China 27 888 1.9× 250 0.6× 161 0.4× 239 0.7× 439 1.8× 105 2.1k
Renqian Zhong China 26 1.2k 2.6× 369 0.9× 277 0.7× 184 0.5× 417 1.7× 56 3.0k
Jérôme Ambroise Belgium 23 551 1.2× 116 0.3× 285 0.8× 143 0.4× 107 0.4× 107 1.6k

Countries citing papers authored by Xin Lü

Since Specialization
Citations

This map shows the geographic impact of Xin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lü more than expected).

Fields of papers citing papers by Xin Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lü. The network helps show where Xin Lü may publish in the future.

Co-authorship network of co-authors of Xin Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Lü. A scholar is included among the top collaborators of Xin Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Lü. Xin Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Shengyong, Shigong Guo, Xue Wang, et al.. (2025). Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review. World Journal of Emergency Medicine. 16(1). 18–18. 1 indexed citations
3.
Wei, Wei, Yanqing Lian, Peng Yao, et al.. (2025). Drug resistance phenotypes of clinical Klebsiella pneumoniae isolates in the past 20 years in China: A systematic review and meta-analysis. International Journal of Antimicrobial Agents. 66(2). 107520–107520.
4.
Yang, Wei, et al.. (2025). Human infective endocarditis and septic shock caused by Streptococcus suis serotype 1. BMC Infectious Diseases. 25(1). 86–86.
5.
Zhu, Shengnan, et al.. (2024). Dynamic changes in the aggregation-depolymerization behavior of Ovomucin-Complex and its binding to urease during in vitro simulated gastric digestion. International Journal of Biological Macromolecules. 270(Pt 1). 132295–132295. 3 indexed citations
6.
Bafadhel, Mona, Stephanie A. Christenson, Claus Vogelmeier, et al.. (2024). IN PATIENTS WITH MODERATE OR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION, DUPILUMAB DOES NOT IMPACT BLOOD EOSINOPHIL LEVELS: PHASE 3 BOREAS TRIAL. CHEST Journal. 166(4). A4831–A4834. 1 indexed citations
7.
Ma, Xiaoyü, et al.. (2024). Subcritical water pretreatment of de-pectin apple pomace for ethanol conversion and whole components utilization. Industrial Crops and Products. 216. 118720–118720. 7 indexed citations
8.
Vogelmeier, Claus, Mona Bafadhel, Stephanie A. Christenson, et al.. (2024). DUPILUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION: THE PHASE 3 NOTUS TRIAL. CHEST Journal. 166(4). A4814–A4818. 1 indexed citations
9.
Vogelmeier, Claus, Mona Bafadhel, Stephanie A. Christenson, et al.. (2024). DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EMPHYSEMA. CHEST Journal. 166(4). A4809–A4813. 1 indexed citations
10.
11.
Jin, Bao, Haifeng Xu, Xin Lü, et al.. (2023). Immune checkpoint inhibitor‐related molecular markers predict prognosis in extrahepatic cholangiocarcinoma. Cancer Medicine. 12(20). 20470–20481. 2 indexed citations
12.
Zhang, Junwei, Xiaobo Yang, Man Li, et al.. (2022). Evolution of associating liver partition and portal vein ligation for staged hepatectomy from 2012 to 2021: A bibliometric analysis. Review. International Journal of Surgery. 103. 106648–106648. 5 indexed citations
13.
Jiang, Shitao, Junwei Zhang, Lei Zhang, et al.. (2022). A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery. Scientific Reports. 12(1). 16466–16466. 10 indexed citations
14.
Yang, Tianyuan, Xin Lü, Xiaomei Yan, et al.. (2021). Shading Promoted Theanine Biosynthesis in the Roots and Allocation in the Shoots of the Tea Plant (Camellia sinensis L.) Cultivar Shuchazao. Journal of Agricultural and Food Chemistry. 69(16). 4795–4803. 44 indexed citations
15.
Lin, Jianzhen, Xinxin Peng, Junyu Long, et al.. (2021). Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nature Communications. 12(1). 4753–4753. 22 indexed citations
16.
Jin, Bao, Wen You, Yang Chen, et al.. (2021). Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer. BMC Cancer. 21(1). 953–953. 5 indexed citations
17.
Jin, Bao, Yue Shi, Haifeng Xu, et al.. (2020). <p>Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy</p>. Cancer Management and Research. Volume 12. 10303–10310. 6 indexed citations
18.
Jin, Bao, Yue Shi, Haifeng Xu, et al.. (2020). <p>Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center</p>. Cancer Management and Research. Volume 12. 411–417. 2 indexed citations
19.
Du, Shunda, Gang Liu, Xinqi Cheng, et al.. (2016). Differential Diagnosis of Immunoglobulin G4-associated Cholangitis From Cholangiocarcinoma. Journal of Clinical Gastroenterology. 50(6). 501–505. 14 indexed citations
20.
Mei, Mei, Yuan‐Jia Chen, Li Zhu, et al.. (2009). Expression and clinical implications of hMSH2 gene in sporadic insnlinomns. 9(1). 5–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Sun Breakdown of academic impact, for papers by Lei Geng Breakdown of academic impact, for papers by Mitsuyoshi Takiguchi Breakdown of academic impact, for papers by Hongyuan Zhou Breakdown of academic impact, for papers by Shayan Mostafaei Breakdown of academic impact, for papers by Zhenhua Luo Breakdown of academic impact, for papers by Hongyan Diao Breakdown of academic impact, for papers by Renqian Zhong Breakdown of academic impact, for papers by Jérôme Ambroise
Rankless by CCL
2026